SCHEMBL4881234

SCHEMBL4881234

CCOC(=O)c1cc(Cl)c(=O)[nH]c1C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.73
MAPT P10636 3/20 0.73
L3MBTL1 Q9Y468 2/20 0.73
LMNA P02545 1/20 0.73
GAA P10253 2/20 0.68
POLB P06746 2/20 0.68
NPC1 O15118 1/20 0.68
PDE3B Q13370 3/20 0.57
PDE3A Q14432 3/20 0.57
KMT2A Q03164 3/20 0.54
KDM4E B2RXH2 3/20 0.54
MEN1 O00255 2/20 0.50
RXFP1 Q9HBX9 1/20 0.50
BAZ2B Q9UIF8 1/20 0.50
BAZ2A Q9UIF9 1/20 0.50
GLA P06280 1/20 0.48
ATM Q13315 1/20 0.48
CDK5 Q00535 2/20 0.47
CDK5R1 Q15078 2/20 0.47
CYP4F2 P78329 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5056804 0.90 ALDH1A1 (0.61) ALDH1A1MAPTL3MBTL1LMNAGAA
SCHEMBL9671945 0.85 ALDH1A1 (1.00) ALDH1A1MAPTL3MBTL1LMNAGAA
SCHEMBL4175783 0.83 PDE3B (0.60) ALDH1A1MAPTL3MBTL1LMNAGAA
SCHEMBL4876345 0.82 ALDH1A1 (0.76) ALDH1A1MAPTL3MBTL1LMNAGAA
SCHEMBL3593126 0.81 ALDH1A1 (0.49) ALDH1A1MAPTL3MBTL1LMNAGAA
SCHEMBL4871436 0.81 GAA (1.00) ALDH1A1MAPTL3MBTL1LMNAGAA
SCHEMBL950017 0.81 ALDH1A1 (0.73) ALDH1A1MAPTL3MBTL1LMNAGAA
SCHEMBL4874543 0.79 ALDH1A1 (0.71) ALDH1A1MAPTL3MBTL1LMNAGAA
SCHEMBL9672980 0.79 ALDH1A1 (0.88) ALDH1A1MAPTL3MBTL1LMNAGAA
SCHEMBL236240 0.79 CYP4F2 (0.57) ALDH1A1MAPTL3MBTL1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312208-A1 Pyridine Analogues ASTRAZENECA AB (SE) 2008-12-18 US disclosed
CN-101263133-A New pyridine analogues ASTRAZENECA AB (SE) 2008-09-10 CN disclosed
EP-1904474-A1 NEW PYRIDINE ANALOGUES AstraZeneca AB (SE) 2008-04-02 EP disclosed
WO-2007008140-A1 NEW PYRIDINE ANALOGUES ASTRAZENECA AB (SE) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312208-A1 Pyridine Analogues P2RY12, P2RY11, P2RY1 ALDH1A1 1274/4885MAPT 4276/4885L3MBTL1 4857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.